Positive results from early trial of drug that could protect brain cells
Date
Research news
Date
This International Day of Women and Girls in Science we’re celebrating some of the pioneering women who are driving Parkinson’s research forward.
Date
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
Date
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson’s.
Date
Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
Date
Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.
Date
Light therapy as a potential treatment for Parkinson’s hits the headlines. We take a deeper look at what we know about it so far.
Date
Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Date
An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
Date
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.